Lila Biologics, Inc. ("Lila Bio") is a biotech company whose mission is to transform patient care by harnessing AI-powered generative protein design and advanced technologies to deliver life-changing therapies to those in need. Lila’s Targeted RadioTherapy (TRT)/Oncology platform is for solid tumor indications, and Lila’s Long-Acting Injectables (LAI) platform is for non-oncology diseases. 

Founded in late 2023, Lila spun out of Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design and is headquartered in the vibrant South Lake Union area of Seattle, WA.

At Lila Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other.  We are committed to building an open, diverse, and inclusive culture for all employees.

Lila Bio

Org chart

Teams

Offices